BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26591679)

  • 21. Clinical implications of directly switching antidepressants in well-treated depressed patients with treatment-emergent sexual dysfunction: a comparison between vortioxetine and escitalopram.
    Jacobsen PL; Nomikos GG; Zhong W; Cutler AJ; Affinito J; Clayton A
    CNS Spectr; 2020 Feb; 25(1):50-63. PubMed ID: 31010445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder.
    Yoshimura R; Hori H; Ikenouchi-Sugita A; Umene-Nakano W; Katsuki A; Atake K; Nakamura J
    Hum Psychopharmacol; 2013 Sep; 28(5):466-70. PubMed ID: 23813968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
    Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
    Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
    Kennedy SH; Andersen HF; Lam RW
    J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder.
    Bakish D; Cavazzoni P; Chudzik J; Ravindran A; Hrdina PD
    Biol Psychiatry; 1997 Jan; 41(2):184-90. PubMed ID: 9018388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Faster onset of antidepressant effects of citalopram compared with sertraline in drug-naïve first-episode major depressive disorder in a Chinese population: a 6-week double-blind, randomized comparative study.
    Hsu JW; Su TP; Huang CY; Chen YS; Chou YH
    J Clin Psychopharmacol; 2011 Oct; 31(5):577-81. PubMed ID: 21869697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of SSRIs on peripheral inflammatory cytokines in patients with Generalized Anxiety Disorder.
    Hou R; Ye G; Liu Y; Chen X; Pan M; Zhu F; Fu J; Fu T; Liu Q; Gao Z; Baldwin DS; Tang Z
    Brain Behav Immun; 2019 Oct; 81():105-110. PubMed ID: 31163212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind, placebo-controlled study of edivoxetine as an adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptake inhibitor treatment.
    Ball S; Dellva MA; D'Souza DN; Marangell LB; Russell JM; Goldberger C
    J Affect Disord; 2014; 167():215-23. PubMed ID: 24995890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Additive effects of acupuncture in alleviating anxiety: A double-blind, three-arm, randomized clinical trial.
    Sabbagh Gol A; Rezaei Ardani A; Farahmand SK; Dadgarmoghaddam M; Ghorani V; Rezaei S; Khorsand A
    Complement Ther Clin Pract; 2021 Nov; 45():101466. PubMed ID: 34388561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mechanisms of liver-soothing and mind-regulating acupuncture mediating opioid receptor participated in the treatment of migraine].
    Liu J; Wang MM; Yang DH; Cui XX
    Zhen Ci Yan Jiu; 2022 Jun; 47(6):510-6. PubMed ID: 35764518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Observation on effective characteristics of acupuncture combined with medicine on depression of different syndrome types].
    Wang XJ; Wang LL; Qiao HF; Li JB
    Zhongguo Zhen Jiu; 2009 Sep; 29(9):699-702. PubMed ID: 19803234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].
    Azorin JM; Llorca PM; Despiegel N; Verpillat P
    Encephale; 2004; 30(2):158-66. PubMed ID: 15107719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized double-blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder.
    Aragona M; Bancheri L; Perinelli D; Tarsitani L; Pizzimenti A; Conte A; Inghilleri M
    Eur J Pain; 2005 Feb; 9(1):33-8. PubMed ID: 15629872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Escitalopram treatment for depressive disorder following acute coronary syndrome: a 24-week double-blind, placebo-controlled trial.
    Kim JM; Bae KY; Stewart R; Jung BO; Kang HJ; Kim SW; Shin IS; Hong YJ; Kim JH; Shin HY; Kang G; Ahn Y; Kim JK; Jeong MH; Yoon JS
    J Clin Psychiatry; 2015 Jan; 76(1):62-8. PubMed ID: 25375836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of interleukin-6 and serotonin as biomarkers to predict response to fluoxetine.
    Manoharan A; Rajkumar RP; Shewade DG; Sundaram R; Muthuramalingam A; Paul A
    Hum Psychopharmacol; 2016 May; 31(3):178-84. PubMed ID: 27018372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness.
    Fava M; Thase ME; DeBattista C
    J Clin Psychiatry; 2005 Jan; 66(1):85-93. PubMed ID: 15669893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bupropion as an augmenting agent in patients of depression with partial response.
    Gulrez G; Badyal DK; Deswal RS; Sharma A
    Basic Clin Pharmacol Toxicol; 2012 Mar; 110(3):227-30. PubMed ID: 21895979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acupuncture combined with repetitive transcranial magnetic stimulation for post-stroke depression: a randomized controlled trial].
    Yin ZL; Ge S; Huang LH; Cao XX; Wu JH
    Zhongguo Zhen Jiu; 2022 Nov; 42(11):1216-20. PubMed ID: 36397217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender-Related Differences in Outcomes on Acupuncture and Moxibustion Treatment Among Depression Patients.
    Fan L; Gong J; Fu W; Chen Z; Xu N; Liu J; Lu A; Li Z; Wu T; Ou A; Xie H
    J Altern Complement Med; 2015 Nov; 21(11):673-80. PubMed ID: 26291873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
    Thase ME; Nierenberg AA; Vrijland P; van Oers HJ; Schutte AJ; Simmons JH
    Int Clin Psychopharmacol; 2010 Jul; 25(4):189-98. PubMed ID: 20531012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.